{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:45:56Z","timestamp":1792089956296,"version":"4.4.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00520-026-11308-3","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:03:13Z","timestamp":1791306193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Time toxicity among patients with cancer: a scoping review"],"prefix":"10.1007","volume":"34","author":[{"given":"He","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuilan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"issue":"5","key":"11308_CR1","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.ccell.2024.03.002","volume":"42","author":"RM Saliby","year":"2024","unstructured":"Saliby RM, Labaki C, Jammihal TR, Xie W, Sun M, Shah V, Saad E, Kane MH, Kashima S, Sadak K, El Zarif T, Poduval D, Motzer RJ, Powles T, Rini BI, Albiges L, Pal SK, McGregor BA, McKay RR, Signoretti S, Van Allen EM, Shukla SA, Choueiri TK, Braun DA (2024) Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes. Cancer Cell 42(5):732\u2013735. https:\/\/doi.org\/10.1016\/j.ccell.2024.03.002","journal-title":"Cancer Cell"},{"issue":"3","key":"11308_CR2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1080\/00325481.2024.2345585","volume":"136","author":"Y Sun","year":"2024","unstructured":"Sun Y, Gong J, Li Z, Han L, Sun D (2024) Gallbladder cancer: surgical treatment, immunotherapy, and targeted therapy. Postgrad Med 136(3):278\u2013291. https:\/\/doi.org\/10.1080\/00325481.2024.2345585","journal-title":"Postgrad Med"},{"key":"11308_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2023.104197","volume":"198","author":"G Wang","year":"2024","unstructured":"Wang G, Huang Y, Zhou L, Yang H, Lin H, Zhou S, Tan Z, Qian J (2024) Immunotherapy and targeted therapy as first-line treatment for advanced gastric cancer. Crit Rev Oncol Hematol 198:104197. https:\/\/doi.org\/10.1016\/j.critrevonc.2023.104197","journal-title":"Crit Rev Oncol Hematol"},{"issue":"15","key":"11308_CR4","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1200\/JCO.21.02810","volume":"40","author":"A Gupta","year":"2022","unstructured":"Gupta A, Eisenhauer EA, Booth ACM (2022) The time toxicity of cancer treatment. J Clin Oncol 40(15):1611\u20131615. https:\/\/doi.org\/10.1200\/JCO.21.02810","journal-title":"J Clin Oncol"},{"key":"11308_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-025-09621-4","author":"SX Stevens","year":"2025","unstructured":"Stevens SX, El-Katateny E, De Abreu Louren\u00e7o R, Booth CM, Shaw J, Vardy JL (2025) \u201cThe cancer is my life\u201d: patient and caregiver perceptions of the time toxicity of palliative systemic cancer treatments for advanced gastrointestinal cancers. Support Care Cancer. https:\/\/doi.org\/10.1007\/s00520-025-09621-4","journal-title":"Support Care Cancer"},{"key":"11308_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyae187","author":"A Gupta","year":"2024","unstructured":"Gupta A, Brundage MD, Galica J, Karim S, Koven R, Ng TL, O\u2019Donnell J, TenHove J, Robinson A, Booth CM (2024) Patients\u2019 considerations of time toxicity when assessing cancer treatments with marginal benefit. Oncologist. https:\/\/doi.org\/10.1093\/oncolo\/oyae187","journal-title":"Oncologist"},{"issue":"4","key":"11308_CR7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.5033","volume":"8","author":"A Gupta","year":"2025","unstructured":"Gupta A, Nguyen P, Wilson BE, Booth CM, Hanna TP (2025) Health care contact days and outcomes in clinical trials vs routine care among patients with non-small cell lung cancer. JAMA Netw Open 8(4):e255033. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.5033","journal-title":"JAMA Netw Open"},{"key":"11308_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-025-09904-w","author":"J Jing","year":"2025","unstructured":"Jing J, Li M, Rui Y, Wang D, Zhu Q, Yuan L (2025) The weight of time: experience of time toxicity among advanced cancer patients and their family caregivers\u2014a qualitative study. Support Care Cancer. https:\/\/doi.org\/10.1007\/s00520-025-09904-w","journal-title":"Support Care Cancer"},{"issue":"1","key":"11308_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/07347332.2021.1899353","volume":"40","author":"MW Flanagan","year":"2022","unstructured":"Flanagan MW, Goltz HH, Henson JW, Smith ML (2022) Associations of practical, emotional, and physical problems with psychosocial distress among cancer patients. J Psychosoc Oncol 40(1):98\u2013114. https:\/\/doi.org\/10.1080\/07347332.2021.1899353","journal-title":"J Psychosoc Oncol"},{"key":"11308_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-024-09132-8","author":"P Sekar","year":"2025","unstructured":"Sekar P, Johnson WV, George M, Breininger A, Parsons HM, Vogel RI, Blaes AH, Gupta A (2025) \u201cThe biggest challenge is there\u2019s never a routine\u201d: a qualitative study of the time burdens of cancer care at home. Support Care Cancer. https:\/\/doi.org\/10.1007\/s00520-024-09132-8","journal-title":"Support Care Cancer"},{"issue":"6","key":"11308_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.16762","volume":"8","author":"AM Duffens","year":"2025","unstructured":"Duffens AM, Zhu S, Shirazi A, Gupta A, Liu R (2025) Telehealth and health care contact days among patients with advanced cancer after COVID-19. JAMA Netw Open 8(6):e2516762. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.16762","journal-title":"JAMA Netw Open"},{"issue":"12","key":"11308_CR12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.49957","volume":"8","author":"RI Vogel","year":"2025","unstructured":"Vogel RI, Jewett P, Parsons H, Brown K, Pecoraro A, Starks I, Ingram S, Huang Z, Oladipo F, Gupta A, Teoh D, Fan Y, Blaes A, Arend R, Rocque G, Wolfson J (2025) Time burden in patients with metastatic breast and ovarian cancer from clinic and home demands. JAMA Netw Open 8(12):e2549957. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.49957","journal-title":"JAMA Netw Open"},{"key":"11308_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyae016","author":"S Kagalwalla","year":"2024","unstructured":"Kagalwalla S, Tsai AK, George M, Waldock A, Davis S, Jewett P, Vogel RI, Ganguli I, Booth C, Dusetzina SB, Rocque GB, Blaes AH, Gupta A (2024) Consuming patients\u2019 days: time spent on ambulatory appointments by people with cancer. Oncologist. https:\/\/doi.org\/10.1093\/oncolo\/oyae016","journal-title":"Oncologist"},{"issue":"10","key":"11308_CR14","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1089\/cbr.2024.0176","volume":"39","author":"JH Turner","year":"2024","unstructured":"Turner JH (2024) Theranostics, advanced cancer, and the meaning of life. Cancer Biother Radiopharm 39(10):707\u2013711. https:\/\/doi.org\/10.1089\/cbr.2024.0176","journal-title":"Cancer Biother Radiopharm"},{"issue":"2","key":"11308_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11864-022-01045-0","volume":"24","author":"P Stone","year":"2023","unstructured":"Stone P, Candelmi DE, Kandola K, Montero L, Smetham D, Suleman S, Fernando A, Roji R (2023) Management of fatigue in patients with advanced cancer. Curr Treat Options Oncol 24(2):93\u2013107. https:\/\/doi.org\/10.1007\/s11864-022-01045-0","journal-title":"Curr Treat Options Oncol"},{"issue":"12","key":"11308_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.25810","volume":"3","author":"A Arastu","year":"2020","unstructured":"Arastu A, Patel A, Mohile SG, Ciminelli J, Kaushik R, Wells M, Culakova E, Lei L, Xu H, Dougherty DW, Mohamed MR, Hill E, Duberstein P, Flannery MA, Kamen CS, Pandya C, Berenberg JL, Grossman VGA, Liu Y, Loh KP (2020) Assessment of financial toxicity among older adults with advanced cancer. JAMA Netw Open 3(12):e2025810. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.25810","journal-title":"JAMA Netw Open"},{"issue":"12","key":"11308_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjon.2024.100610","volume":"11","author":"C Nwozichi","year":"2024","unstructured":"Nwozichi C, Omolabake S, Ojewale MO, Faremi F, Brotobor D, Olaogun E, Oshodi-Bakare M, Martins-Akinlose O (2024) Time toxicity in cancer care: a concept analysis using Walker and Avant\u2019s method. Asia Pac J Oncol Nurs 11(12):100610. https:\/\/doi.org\/10.1016\/j.apjon.2024.100610","journal-title":"Asia Pac J Oncol Nurs"},{"issue":"2","key":"11308_CR18","doi-asserted-by":"publisher","first-page":"S1114","DOI":"10.1016\/j.annonc.2023.09.920","volume":"34","author":"C Cronin","year":"2023","unstructured":"Cronin C, O\u2019Sullivan DT, Ronan K, Hannan M, Horgan AM (2023) 2138P time toxicity of palliative chemotherapy in a geriatric oncology population. Ann Oncol 34(2):S1114. https:\/\/doi.org\/10.1016\/j.annonc.2023.09.920","journal-title":"Ann Oncol"},{"issue":"3","key":"11308_CR19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10549-024-07379-7","volume":"207","author":"SY Atre","year":"2024","unstructured":"Atre SY, Soulos PR, Kuderer NM, Gross CP, Baum LVM, Dinan MA, Lustberg MB (2024) Characterization of time toxicity in older patients with metastatic breast cancer. Breast Cancer Res Treat 207(3):541\u2013550. https:\/\/doi.org\/10.1007\/s10549-024-07379-7","journal-title":"Breast Cancer Res Treat"},{"key":"11308_CR20","doi-asserted-by":"publisher","DOI":"10.1200\/op-24-00526","author":"AG Ording","year":"2024","unstructured":"Ording AG, Skj\u00f8th F, Poulsen L\u00d8, Szejniuk WM, Jakobsen E, Christensen TD, Noble S, Overvad TF (2024) Time toxicity of systemic anticancer therapy for metastatic lung cancer in routine clinical practice: a nationwide cohort study. JCO Oncol Pract. https:\/\/doi.org\/10.1200\/op-24-00526","journal-title":"JCO Oncol Pract"},{"key":"11308_CR21","doi-asserted-by":"publisher","DOI":"10.1200\/op-25-00412","author":"U Nindra","year":"2025","unstructured":"Nindra U, Tang J, Hong JH, Descallar J, Hong M, Killen A, Dubey P, Attaullah J, Scott G, Cooper A, Wilkinson K, Pal A, Teng C, Roohullah A, Wei J, Ng W, Lemech C, Chua W (2025) Assessing patient-reported financial, social, and time toxicity in early-phase cancer clinical trials in Australia through a prospective multicenter nonrandomized cohort study. JCO Oncol Pract. https:\/\/doi.org\/10.1200\/op-25-00412","journal-title":"JCO Oncol Pract"},{"issue":"6","key":"11308_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.102046","volume":"8","author":"U Nindra","year":"2023","unstructured":"Nindra U, Shivasabesan G, Childs S, Yoon R, Haider S, Hong M, Cooper A, Roohullah A, Wilkinson K, Pal A, Chua W (2023) Time toxicity associated with early phase clinical trial participation. ESMO Open 8(6):102046. https:\/\/doi.org\/10.1016\/j.esmoop.2023.102046","journal-title":"ESMO Open"},{"key":"11308_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-026-10359-w","author":"RH Nguyen","year":"2026","unstructured":"Nguyen RH, Tang J, Nindra U, Roohullah A, Yoon R, Tognela A, Lim SH, Asghari R, Chua W, Ng W (2026) Time toxicity associated with treatment of metastatic or unresectable gastro-oesophageal cancers in the second-line setting. Support Care Cancer. https:\/\/doi.org\/10.1007\/s00520-026-10359-w","journal-title":"Support Care Cancer"},{"issue":"9","key":"11308_CR24","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1200\/op.23.00811","volume":"20","author":"SM Durbin","year":"2024","unstructured":"Durbin SM, Lundquist DM, Pelletier A, Jimenez R, Petrillo L, Kim J, Lynch K, Healy M, Johnson A, Ollila N, Yalala V, Malowitz B, Kehlmann A, Chevalier N, Turbini V, Bame V, Heldreth H, Silva J, McIntyre C, Juric D, Nipp RD (2024) Time toxicity experienced by early-phase cancer clinical trial participants. JCO Oncol Pract 20(9):1252\u20131262. https:\/\/doi.org\/10.1200\/op.23.00811","journal-title":"JCO Oncol Pract"},{"issue":"9","key":"11308_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-024-08844-1","volume":"32","author":"JC Baltussen","year":"2024","unstructured":"Baltussen JC, C\u00e1rdenas-Reyes P, Chavarri-Guerra Y, Ramirez-Fontes A, Morales-Alfaro A, Portielje JEA, Ramos-Lopez WA, Rosado-Canto V, Soto-Perez-de-Celis E (2024) Time toxicity among older patients with cancer treated with palliative systemic therapy. Support Care Cancer 32(9):621. https:\/\/doi.org\/10.1007\/s00520-024-08844-1","journal-title":"Support Care Cancer"},{"key":"11308_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/spcare-2025-005738","author":"S Mailankody","year":"2025","unstructured":"Mailankody S, Kotian D, Udupa KS, Pai A, Shetty P, Guddattu V, Ganesan P (2025) Time toxicity during palliative chemotherapy for advanced malignancies: a prospective study. BMJ Support Palliat Care. https:\/\/doi.org\/10.1136\/spcare-2025-005738","journal-title":"BMJ Support Palliat Care"},{"issue":"6","key":"11308_CR27","doi-asserted-by":"publisher","first-page":"e859","DOI":"10.1200\/op.22.00737","volume":"19","author":"A Gupta","year":"2023","unstructured":"Gupta A, O\u2019Callaghan CJ, Zhu L, Jonker DJ, Wong RPW, Colwell B, Moore MJ, Karapetis CS, Tebbutt NC, Shapiro JD, Tu D, Booth CM (2023) Evaluating the time toxicity of cancer treatment in the CCTG CO.17 trial. JCO Oncol Pract 19(6):e859\u2013e866. https:\/\/doi.org\/10.1200\/op.22.00737","journal-title":"JCO Oncol Pract"},{"issue":"7","key":"11308_CR28","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00520-007-0380-2","volume":"16","author":"DH Henry","year":"2008","unstructured":"Henry DH, Viswanathan HN, Elkin EP, Traina S, Wade S, Cella D (2008) Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S. Support Care Cancer 16(7):791\u2013801. https:\/\/doi.org\/10.1007\/s00520-007-0380-2","journal-title":"Support Care Cancer"},{"issue":"11","key":"11308_CR29","doi-asserted-by":"publisher","DOI":"10.1097\/gox.0000000000003904","volume":"9","author":"CW Swanick","year":"2021","unstructured":"Swanick CW, Jiang J, Maldonado JA, Lei X, Shih YT, Caudle AS, Baumann DP, Giordano SH, Shaitelman SF, Shirvani SM, Smith BD (2021) Differences in time burden across local therapy strategies for early-stage breast cancer. Plast Reconstr Surg Glob Open 9(11):e3904. https:\/\/doi.org\/10.1097\/gox.0000000000003904","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"23","key":"11308_CR30","doi-asserted-by":"publisher","first-page":"5677","DOI":"10.3390\/cancers15235677","volume":"15","author":"NY Agrawal","year":"2023","unstructured":"Agrawal NY, Thawani R, Edmondson CP, Chen EY (2023) Estimating the time toxicity of contemporary systemic treatment regimens for advanced esophageal and gastric cancers. Cancers (Basel) 15(23):5677. https:\/\/doi.org\/10.3390\/cancers15235677","journal-title":"Cancers (Basel)"},{"key":"11308_CR31","doi-asserted-by":"publisher","DOI":"10.1056\/cat.24.0201","author":"EM Bange","year":"2025","unstructured":"Bange EM, Coughlin KQ, Li W, Brown TJ, Ragusano D, Balar E, Arasappan D, Nnaji M, Kim E, Alban C, Uppuluri S, Moriarty E, Bange T, Zinck L, Smith D, Josephs M, Harrigan JJ, Cohen RB, Zubka D, Rosin R, Balachandran M, Long Q, Bilger A, Schuchter LM, Mamtani M, Shulman LN, Guerra CE, Mamtani R (2025) A text message intervention to minimize the time burden of cancer care. NEJM Catal. https:\/\/doi.org\/10.1056\/cat.24.0201","journal-title":"NEJM Catal"},{"issue":"7","key":"11308_CR32","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tuncalp O, Straus SE (2018) PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169(7):467\u2013473. https:\/\/doi.org\/10.7326\/M18-0850","journal-title":"Ann Intern Med"},{"issue":"10","key":"11308_CR33","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","volume":"18","author":"MDJ Peters","year":"2020","unstructured":"Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, McInerney P, Godfrey CM, Khalil H (2020) Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth 18(10):2119\u20132126. https:\/\/doi.org\/10.11124\/JBIES-20-00167","journal-title":"JBI Evid Synth"},{"issue":"2","key":"11308_CR34","doi-asserted-by":"publisher","DOI":"10.3171\/2025.5.focus25331","volume":"59","author":"AL Fecker","year":"2025","unstructured":"Fecker AL, Stateler C, Joyce M, Sengupta S, Minns HE, Nugent JG, Smith JL, Han SJ, Wood MD, Raslan AM, Barajas RF, Bowden SG (2025) The effect of tumor growth kinetics on survival and time toxicity after resection of recurrent glioblastoma. Neurosurg Focus 59(2):E3. https:\/\/doi.org\/10.3171\/2025.5.focus25331","journal-title":"Neurosurg Focus"},{"key":"11308_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-025-09335-7","author":"H Araie","year":"2025","unstructured":"Araie H, Seki T, Okada A, Yamauchi T, Nangaku M, Kadowaki T, Ohe K, Yamauchi T, Yamaguchi S (2025) Temporal trends in time toxicity of R-CHOP: a nationwide hospital-based database analysis in Japan. Support Care Cancer. https:\/\/doi.org\/10.1007\/s00520-025-09335-7","journal-title":"Support Care Cancer"},{"issue":"6","key":"11308_CR36","doi-asserted-by":"publisher","first-page":"538","DOI":"10.14740\/wjon2637","volume":"16","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Fitzpatrick M, Ojha S, Hurtado-Castillo M, Sessions W, Aung K, Pandey O, Goodgame B (2025) Measuring the unseen burden: immunotherapy and targeted therapy reduce treatment-related time toxicity in incurable malignancies. World J Oncol 16(6):538\u2013545. https:\/\/doi.org\/10.14740\/wjon2637","journal-title":"World J Oncol"},{"issue":"11","key":"11308_CR37","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.3179","volume":"159","author":"SB Bateni","year":"2023","unstructured":"Bateni SB, Nguyen P, Eskander A, Seung SJ, Mittmann N, Jalink M, Gupta A, Chan KKW, Hong NJL, Hanna TP (2023) Changes in health care costs, survival, and time toxicity in the era of immunotherapy and targeted systemic therapy for melanoma. JAMA Dermatol 159(11):1195. https:\/\/doi.org\/10.1001\/jamadermatol.2023.3179","journal-title":"JAMA Dermatol"},{"key":"11308_CR38","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jss.2019.12.035","volume":"251","author":"A Manjunathan","year":"2020","unstructured":"Manjunathan A, Gupta S, Kein C, Yang S, Mazurek A, Reddy RM (2020) A streamlined preoperative surgical oncology clinic workflow reduces patient burden. J Surg Res 251:146\u2013151. https:\/\/doi.org\/10.1016\/j.jss.2019.12.035","journal-title":"J Surg Res"},{"issue":"2","key":"11308_CR39","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s40271-025-00778-y","volume":"19","author":"SX Stevens","year":"2026","unstructured":"Stevens SX, El-Katateny E, Addo IY, Street D, Booth C, Shaw J, Vardy JL, Lourenco RDA (2026) How important is healthcare-contact time to systemic treatment decision-making in advanced gastrointestinal cancers: developing attributes to include in a discrete choice experiment. Patient-Patient-Centered Outcomes Res 19(2):269\u2013284. https:\/\/doi.org\/10.1007\/s40271-025-00778-y","journal-title":"Patient-Patient-Centered Outcomes Res"},{"issue":"11","key":"11308_CR40","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00520-025-09954-0","volume":"33","author":"WV Johnson","year":"2025","unstructured":"Johnson WV, Valisekka SS, Ogunleye OO, Stevens SX, George M, Breininger A, Kyle MA, Booth CM, Hanna TP, Vogel RI, Parsons HM, Blaes AH, Gupta A (2025) Patient-, care partner-, and clinician-proposed solutions to address the time toxicity of cancer care. Support Care Cancer 33(11):965. https:\/\/doi.org\/10.1007\/s00520-025-09954-0","journal-title":"Support Care Cancer"},{"issue":"11","key":"11308_CR41","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.47649","volume":"7","author":"A Gupta","year":"2024","unstructured":"Gupta A, Johnson WV, Henderson NL, Ogunleye OO, Sekar P, George M, Breininger A, Kyle MA, Booth CM, Hanna TP, Rocque GB, Parsons HM, Vogel RI, Blaes AH (2024) Patient, caregiver, and clinician perspectives on the time burdens of cancer care. JAMA Netw Open 7(11):e2447649. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.47649","journal-title":"JAMA Netw Open"},{"issue":"22","key":"11308_CR42","doi-asserted-by":"publisher","first-page":"8423","DOI":"10.1002\/cam4.3461","volume":"9","author":"GB Rocque","year":"2020","unstructured":"Rocque GB, Williams CP, Ingram SA, Azuero A, Mennemeyer ST, Pierce JY, Nipp RD, Hayes KER, Kenzik KM (2020) Health care-related time costs in patients with metastatic breast cancer. Cancer Med 9(22):8423\u20138431. https:\/\/doi.org\/10.1002\/cam4.3461","journal-title":"Cancer Med"},{"issue":"5","key":"11308_CR43","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s00520-012-1671-9","volume":"21","author":"S Shreay","year":"2012","unstructured":"Shreay S, Desrosiers M, Corey-Lisle P, Payne K (2012) A retrospective study to evaluate the time burden associated with outpatient red blood transfusions indicated for anemia due to concomitantly administered chemotherapy in cancer patients. Support Care Cancer 21(5):1335\u20131340. https:\/\/doi.org\/10.1007\/s00520-012-1671-9","journal-title":"Support Care Cancer"},{"issue":"6","key":"11308_CR44","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/jama.2024.10398","volume":"332","author":"JS Temel","year":"2024","unstructured":"Temel JS, Jackson VA, El-Jawahri A, Rinaldi SP, Petrillo LA, Kumar P, McGrath KA, LeBlanc TW, Kamal AH, Jones CA, Rabideau DJ, Horick N, Pintro K, Medeiros ERG, Post KE, Greer JA (2024) Stepped palliative care for patients with advanced lung cancer: a randomized clinical trial. JAMA 332(6):471\u2013481. https:\/\/doi.org\/10.1001\/jama.2024.10398","journal-title":"JAMA"},{"key":"11308_CR45","doi-asserted-by":"publisher","unstructured":"Liu M, Chen H, Zhao H, Li Y, Zhuang Y (2025) Dual dimensions of psychological resilience in cancer patients: a systematic review from risk factors to protective factors.\u00a0Psycho-Oncologie 19(4):4512. https:\/\/doi.org\/10.18282\/po4512.","DOI":"10.18282\/po4512"},{"issue":"4","key":"11308_CR46","doi-asserted-by":"publisher","first-page":"E229","DOI":"10.1097\/ncc.0000000000000717","volume":"43","author":"J Ruan","year":"2020","unstructured":"Ruan J, Qian Y, Zhuang Y, Zhou Y (2020) The illness experiences of Chinese patients living with lymphoma. Cancer Nurs 43(4):E229\u2013E238. https:\/\/doi.org\/10.1097\/ncc.0000000000000717","journal-title":"Cancer Nurs"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11308-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11308-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11308-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:47:44Z","timestamp":1792086464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11308-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11308"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11308-3","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"12 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1066"}}